
Title: Oncology Account Manager
Reports To: Executive Regional Business Director
Location: Field-Based (North Boston, MA)
Classification: Exempt
Coherus Oncology is a fully integrated, commercial stage innovative oncology company whose main focus is developing promising immuno-oncology products that improve the lives of patients. As the Oncology Account Manager, you will be a key member of our customer facing team selling LOQTORZI and partnering with HCPs and other influential oncology practice stakeholders committed to a patient-centric approach of cancer care delivery.
The Oncology Account Manager role requires the building of sustained relationships with physicians, pharmacists, nurses, administrators, billing, finance, office practice managers mid-levels and other pertinent staff. A deep understanding of cancer staging and clinical guidelines, as well as overall product, reimbursement and financial acumen will be required for this role.
Essential Duties and Responsibilities:
Experience, Education, Training, Traits:
The Base Salary Range for this position is $150,000 to $200,000. Coherus considers various factors, including professional background and work experience, when determining base pay. These considerations mean actual compensation will vary.
Coherus provides equal employment opportunities to all employees and applicants for employment and prohibits unlawful discrimination and harassment of any type without regard to race, color, religion, age, sex, national origin, disability status, genetics, protected veteran status, sexual orientation, gender identity or expression, or any other characteristic protected by federal, state or local laws. We also prohibit discrimination based on the perception that anyone has any of these characteristics or is associated with a person who has or is perceived as having any of these characteristics.
** We are currently not accepting any unsolicited resumes from recruiters or employment agencies. **

Coherus Oncology is a fully integrated commercial-stage innovative oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a promising pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Our strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both our pipeline candidates as well as our industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents.
If you are interested in joining a highly innovative and exciting company, please visit our careers webpage at http://www.coherus.com/careers/ for a list of career opportunities.